MedPath

A trial to see which form of the drug Misoprostol used for induction of labour is more effective and safer- in fluid form given at regular intervals starting at low dose or as a tablet with fixed dose.

Phase 4
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2023/03/051096
Lead Sponsor
Rajagiri Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. primigravida

2. 37-40 weeks of pregnancy

3. singleton pregnancy with cephalic presentation

4. no uterine scar

5. Bishop score less than or equal to 6

Exclusion Criteria

1.women with contraindications or hypersensitivity to misoprostol

2. women who do not consent to partiipate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath